Trials / Sponsors / VivaVision Biotech, Inc
VivaVision Biotech, Inc
Industry · 8 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray Chronic Rhinosinusitis (CRS) | Phase 1 | 2025-11-06 |
| Not Yet Recruiting | A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis Non-infectious Anterior Uveitis | Phase 3 | 2025-10-01 |
| Recruiting | Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease Dry Eye | Phase 3 | 2024-04-01 |
| Completed | Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery Inflammation | Phase 2 | 2024-01-11 |
| Completed | A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis Anterior Uveitis | Phase 2 | 2023-11-27 |
| Completed | Pharmacokinetics of VVN461 Ophthalmic Solution Healthy Volunteers | Phase 1 | 2023-03-01 |
| Completed | A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure Glaucoma, Open-Angle | Phase 2 | 2022-07-12 |
| Completed | Study of VVN001 Ophthalmic Solution in Dry Eye Disease Dry Eye | Phase 2 | 2020-12-03 |